Advanced

The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections.

Wagenlehner, Florian; Tandogdu, Zafer; Bartoletti, Riccardo; Cai, Tommaso; Cek, Mete; Kulchavenya, Ekaterina; Köves, Béla; Naber, Kurt; Perepanova, Tamara and Tenke, Peter, et al. (2016) In Pathogens (Basel, Switzerland) 5(1).
Abstract
The Global Prevalence of Infections in Urology (GPIU) study is a worldwide-performed point prevalence study intended to create surveillance data on antibiotic resistance, type of urogenital infections, risk factors and data on antibiotic consumption, specifically in patients at urological departments with healthcare-associated urogenital infections (HAUTI). Investigators registered data through a web-based application (http://gpiu.esiu.org/). Data collection includes the practice and characteristics of the hospital and urology ward. On a certain day in November, each year, all urological patients present in the urological department at 8:00 a.m. are screened for HAUTI encompassing their full hospital course from admission to discharge.... (More)
The Global Prevalence of Infections in Urology (GPIU) study is a worldwide-performed point prevalence study intended to create surveillance data on antibiotic resistance, type of urogenital infections, risk factors and data on antibiotic consumption, specifically in patients at urological departments with healthcare-associated urogenital infections (HAUTI). Investigators registered data through a web-based application (http://gpiu.esiu.org/). Data collection includes the practice and characteristics of the hospital and urology ward. On a certain day in November, each year, all urological patients present in the urological department at 8:00 a.m. are screened for HAUTI encompassing their full hospital course from admission to discharge. Apart from the GPIU main study, several side studies are taking place, dealing with transurethral resection of the prostate, prostate biopsy, as well as urosepsis. The GPIU study has been annually performed since 2003. Eight-hundred fifty-six urology units from 70 countries have participated so far, including 27,542 patients. A proxy for antibiotic consumption is reflected by the application rates used for antibiotic prophylaxis for urological interventions. Resistance rates of most uropathogens against antibiotics were high, especially with a note of multidrug resistance. The severity of HAUTI is also increasing, 25% being urosepsis in recent years. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Pathogens (Basel, Switzerland)
volume
5
issue
1
publisher
MDPI Ag
external identifiers
  • PMID:26797640
  • WOS:000373680700005
ISSN
2076-0817
DOI
10.3390/pathogens5010010
language
English
LU publication?
yes
id
90dc7ed1-c119-4320-8d67-ad5c6c1a8fc6 (old id 8576595)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26797640?dopt=Abstract
date added to LUP
2016-02-03 21:54:31
date last changed
2016-09-20 03:04:45
@misc{90dc7ed1-c119-4320-8d67-ad5c6c1a8fc6,
  abstract     = {The Global Prevalence of Infections in Urology (GPIU) study is a worldwide-performed point prevalence study intended to create surveillance data on antibiotic resistance, type of urogenital infections, risk factors and data on antibiotic consumption, specifically in patients at urological departments with healthcare-associated urogenital infections (HAUTI). Investigators registered data through a web-based application (http://gpiu.esiu.org/). Data collection includes the practice and characteristics of the hospital and urology ward. On a certain day in November, each year, all urological patients present in the urological department at 8:00 a.m. are screened for HAUTI encompassing their full hospital course from admission to discharge. Apart from the GPIU main study, several side studies are taking place, dealing with transurethral resection of the prostate, prostate biopsy, as well as urosepsis. The GPIU study has been annually performed since 2003. Eight-hundred fifty-six urology units from 70 countries have participated so far, including 27,542 patients. A proxy for antibiotic consumption is reflected by the application rates used for antibiotic prophylaxis for urological interventions. Resistance rates of most uropathogens against antibiotics were high, especially with a note of multidrug resistance. The severity of HAUTI is also increasing, 25% being urosepsis in recent years.},
  author       = {Wagenlehner, Florian and Tandogdu, Zafer and Bartoletti, Riccardo and Cai, Tommaso and Cek, Mete and Kulchavenya, Ekaterina and Köves, Béla and Naber, Kurt and Perepanova, Tamara and Tenke, Peter and Wullt, Björn and Bogenhard, Florian and Johansen, Truls Erik Bjerklund},
  issn         = {2076-0817},
  language     = {eng},
  number       = {1},
  publisher    = {ARRAY(0x9830868)},
  series       = {Pathogens (Basel, Switzerland)},
  title        = {The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections.},
  url          = {http://dx.doi.org/10.3390/pathogens5010010},
  volume       = {5},
  year         = {2016},
}